513 Trial in progress: phase 1 first-in-human study of XL092 administered alone or in combination with immune checkpoint inhibitors in patients with inoperable locally advanced or... oleh Vivek Subbiah, Neeraj Agarwal, Sumanta Pal, Amita Patnaik, Manish Sharma, Edward Cha, Geoffrey Shapiro, Kristopher Wentzel, Elizabeth McIlvaine, Jana Waldes, Keyvan Tadjalli-Mehr